{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:15:06Z","timestamp":1792725306006,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03428"],"award-info":[{"award-number":["19H03428"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H05111"],"award-info":[{"award-number":["21H05111"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K02231"],"award-info":[{"award-number":["24K02231"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The \u03ba-opioid receptor (KOR) is a member of the G protein-coupled receptor (GPCR) family, modulating cellular responses through transducers such as G proteins and \u03b2-arrestins. G-protein-biased KOR agonists aim to retain analgesic and antipruritic actions while limiting aversion and sedation. Aiming to inform G-biased KOR agonist design, we analyze signaling-relevant residues from structural and dynamic views. Here we show, using multiple complementary methods, shared residues that determine \u03b2-arrestin recruitment by nalfurafine and U-50,488H. Cryo-electron microscopy structures of the KOR-G\n                    <jats:sub>i<\/jats:sub>\n                    signaling complexes identify the ligand binding mode in the activated state. Vibrational spectroscopy reveals ligand-induced conformational changes. Cell-based mutant experiments pinpoint four amino acids (K227\n                    <jats:sup>5.40<\/jats:sup>\n                    , C286\n                    <jats:sup>6.47<\/jats:sup>\n                    , H291\n                    <jats:sup>6.52<\/jats:sup>\n                    , and Y312\n                    <jats:sup>7.34<\/jats:sup>\n                    ; Ballesteros\u2013Weinstein numbering is shown in superscript) that play crucial roles in \u03b2-arrestin recruitment. Furthermore, MD simulations revealed that the four mutants tend to adopt conformations with reduced \u03b2-arrestin recruitment activity. Our research findings provide a foundation for enhancing KOR-mediated therapeutic effects while minimizing unwanted side effects by targeting specific residues within the KOR ligand-binding pocket, including K227\n                    <jats:sup>5.40<\/jats:sup>\n                    and Y312\n                    <jats:sup>7.34<\/jats:sup>\n                    , which have previously been implicated in biased signaling.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-64882-1","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:04:29Z","timestamp":1761645869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Structural and dynamic insights into the biased signaling mechanism of the human kappa opioid receptor"],"prefix":"10.1038","volume":"16","author":[{"given":"Chiyo","family":"Suno-Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-3832","authenticated-orcid":false,"given":"Riko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-3420","authenticated-orcid":false,"given":"Shun","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Takai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risako","family":"Katamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6583-1719","authenticated-orcid":false,"given":"Ryoji","family":"Kise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6861-4840","authenticated-orcid":false,"given":"Yukihiko","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-6685","authenticated-orcid":false,"given":"Takayuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0428-3979","authenticated-orcid":false,"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4194-7255","authenticated-orcid":false,"given":"Ayori","family":"Mitsutake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-6292","authenticated-orcid":false,"given":"Tsuyoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8498-4374","authenticated-orcid":false,"given":"Kota","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-4049","authenticated-orcid":false,"given":"Asuka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-1344","authenticated-orcid":false,"given":"Hideki","family":"Kandori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6270-1353","authenticated-orcid":false,"given":"Takuya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-236X","authenticated-orcid":false,"given":"Ryoji","family":"Suno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"64882_CR1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1146\/annurev-biochem-060614-033910","volume":"87","author":"WI Weis","year":"2018","unstructured":"Weis, W. I. & Kobilka, B. K. The molecular basis of G protein-coupled receptor activation. Annu. Rev. Biochem. 87, 897\u2013919 (2018).","journal-title":"Annu. Rev. Biochem."},{"key":"64882_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-pharmtox-052120-091058","volume":"63","author":"E Kelly","year":"2023","unstructured":"Kelly, E., Conibear, A. & Henderson, G. Biased agonism: lessons from studies of opioid receptor agonists. Annu. Rev. Pharm. Toxicol. 63, 491\u2013515 (2023).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"64882_CR3","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","volume":"27","author":"MR Bruchas","year":"2007","unstructured":"Bruchas, M. R. et al. Stress-induced p38 mitogen-activated protein kinase activation mediates \u03ba-opioid-dependent dysphoria. J. Neurosci. 27, 11614\u201311623 (2007).","journal-title":"J. Neurosci."},{"key":"64882_CR4","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1523\/JNEUROSCI.22-23-10494.2002","volume":"22","author":"LM Bohn","year":"2002","unstructured":"Bohn, L. M., Lefkowitz, R. J. & Caron, M. G. Differential mechanisms of morphine antinociceptive tolerance revealed in \u03b2arrestin-2 knock-out mice. J. Neurosci. 22, 10494\u201310500 (2002).","journal-title":"J. Neurosci."},{"key":"64882_CR5","doi-asserted-by":"publisher","first-page":"eaar4309","DOI":"10.1126\/scisignal.aar4309","volume":"11","author":"JH Ho","year":"2018","unstructured":"Ho, J. H. et al. G protein signaling-biased agonism at the k-opioid receptor is maintained in striatal neurons. Sci. Signal. 11, eaar4309 (2018).","journal-title":"Sci. Signal."},{"key":"64882_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2011.06.008","volume":"32","author":"AA Pradhan","year":"2011","unstructured":"Pradhan, A. A., Befort, K., Nozaki, C., Gav\u00e9riaux-Ruff, C. & Kieffer, B. L. The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharm. Sci. 32, 581\u2013590 (2011).","journal-title":"Trends Pharm. Sci."},{"key":"64882_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","volume":"19","author":"D Wootten","year":"2018","unstructured":"Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M. & Sexton, P. M. Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 19, 638\u2013653 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"64882_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tibs.2022.03.009","volume":"47","author":"M Seyedabadi","year":"2022","unstructured":"Seyedabadi, M., Gharghabi, M., Gurevich, E. V. & Gurevich, V. V. Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling. Trends Biochem. Sci. 47, 570\u2013581 (2022).","journal-title":"Trends Biochem. Sci."},{"key":"64882_CR9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1039\/D1MD00041A","volume":"12","author":"J De Neve","year":"2021","unstructured":"De Neve, J. et al. Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors. RSC Med. Chem. 12, 828\u2013870 (2021).","journal-title":"RSC Med. Chem."},{"key":"64882_CR10","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1016\/j.bmcl.2010.08.083","volume":"20","author":"H Nagase","year":"2010","unstructured":"Nagase, H. et al. Design and synthesis of KNT-127, a \u03b4-opioid receptor agonist effective by systemic administration. Bioorg. Med. Chem. Lett. 20, 6302\u20136305 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"64882_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbr.2011.04.041","volume":"223","author":"A Saitoh","year":"2011","unstructured":"Saitoh, A. et al. The novel \u03b4 opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav. Brain Res. 223, 271\u2013279 (2011).","journal-title":"Behav. Brain Res."},{"key":"64882_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.837671","volume":"13","author":"ML Dalefield","year":"2022","unstructured":"Dalefield, M. L., Scouller, B., Bibi, R. & Kivell, B. M. The kappa opioid receptor: a promising therapeutic target for multiple pathologies. Front. Pharm. 13, 1\u201326 (2022).","journal-title":"Front. Pharm."},{"key":"64882_CR13","doi-asserted-by":"publisher","first-page":"27050","DOI":"10.1074\/jbc.C112.387332","volume":"287","author":"ML Rives","year":"2012","unstructured":"Rives, M. L., Rossillo, M., Liu-Chen, L. Y. & Javitch, J. A. 6\u2032-Guanidinonaltrindole (6\u2032-GNTI) is a G protein-biased \u03ba-opioid receptor agonist that inhibits arrestin recruitment. J. Biol. Chem. 287, 27050\u201327054 (2012).","journal-title":"J. Biol. Chem."},{"key":"64882_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aai8441","volume":"9","author":"TF Brust","year":"2016","unstructured":"Brust, T. F. et al. Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Sci. Signal 9, 1\u201311 (2016).","journal-title":"Sci. Signal"},{"key":"64882_CR15","doi-asserted-by":"crossref","unstructured":"White, K. L. et al. The G protein-biased \u03ba-Opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo. J. Pharmacol. Exp. Ther. 352, 98\u2013109 (2015).","DOI":"10.1124\/jpet.114.216820"},{"key":"64882_CR16","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.cell.2023.10.029","volume":"186","author":"T Che","year":"2023","unstructured":"Che, T. & Roth, B. L. Molecular basis of opioid receptor signaling. Cell 186, 5203\u20135219 (2023).","journal-title":"Cell"},{"key":"64882_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37041-7","volume":"14","author":"A El Daibani","year":"2023","unstructured":"El Daibani, A. et al. Molecular mechanism of biased signaling at the kappa opioid receptor. Nat. Commun. 14, 1338 (2023).","journal-title":"Nat. Commun."},{"key":"64882_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cell.2017.12.011","volume":"172","author":"T Che","year":"2018","unstructured":"Che, T. et al. Structure of the nanobody-stabilized active state of the kappa opioid receptor. Cell 172, 55\u201367.e15 (2018).","journal-title":"Cell"},{"key":"64882_CR19","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1021\/acs.jpclett.9b02942","volume":"10","author":"K Katayama","year":"2019","unstructured":"Katayama, K. et al. Ligand binding-induced structural changes in the M2 muscarinic acetylcholine receptor revealed by vibrational spectroscopy. J. Phys. Chem. Lett. 10, 7270\u20137276 (2019).","journal-title":"J. Phys. Chem. Lett."},{"key":"64882_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02836-1","volume":"4","author":"K Katayama","year":"2021","unstructured":"Katayama, K. et al. Vibrational spectroscopy analysis of ligand efficacy in human M2 muscarinic acetylcholine receptor (M2R). Commun. Biol. 4, 1\u201312 (2021).","journal-title":"Commun. Biol."},{"key":"64882_CR21","doi-asserted-by":"publisher","first-page":"12559","DOI":"10.1039\/D1RA01030A","volume":"11","author":"K Suzuki","year":"2021","unstructured":"Suzuki, K. et al. Vibrational analysis of acetylcholine binding to the M2receptor. RSC Adv. 11, 12559\u201312567 (2021).","journal-title":"RSC Adv."},{"key":"64882_CR22","doi-asserted-by":"publisher","first-page":"10187","DOI":"10.1021\/bi990631+","volume":"38","author":"T Noguchi","year":"1999","unstructured":"Noguchi, T., Inoue, Y. & Tang, X. S. Structure of a histidine ligand in the photosynthetic oxygen-evolving complex as studied by light-induced Fourier transform infrared difference spectroscopy. Biochemistry 38, 10187\u201310195 (1999).","journal-title":"Biochemistry"},{"key":"64882_CR23","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1021\/ja980837i","volume":"120","author":"H Kandori","year":"1998","unstructured":"Kandori, H. et al. Cysteine S-H as a hydrogen-bonding probe in proteins [12]. J. Am. Chem. Soc. 120, 5828\u20135829 (1998).","journal-title":"J. Am. Chem. Soc."},{"key":"64882_CR24","doi-asserted-by":"crossref","unstructured":"Bouysset, C. & Fiorucci, S. ProLIF: a library to encode molecular interactions as fingerprints. J. Cheminform. 13, 1\u20139 (2021).","DOI":"10.1186\/s13321-021-00548-6"},{"key":"64882_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.aaz0326","volume":"367","author":"CM Suomivuori","year":"2020","unstructured":"Suomivuori, C. M. et al. Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor. Science 367, 881\u2013887 (2020).","journal-title":"Science"},{"key":"64882_CR26","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1021\/acs.jpcb.4c00730","volume":"128","author":"S Yokoi","year":"2024","unstructured":"Yokoi, S., Suno, R. & Mitsutake, A. Structural and computational insights into dynamics and intermediate states of orexin 2 receptor signaling. J. Phys. Chem. B 128, 6082\u20136096 (2024).","journal-title":"J. Phys. Chem. B"},{"key":"64882_CR27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41586-020-2419-1","volume":"583","author":"Y Lee","year":"2020","unstructured":"Lee, Y. et al. Molecular basis of \u03b2-arrestin coupling to formoterol-bound \u03b21-adrenoceptor. Nature 583, 862\u2013866 (2020).","journal-title":"Nature"},{"key":"64882_CR28","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","volume":"185","author":"Y Zhuang","year":"2022","unstructured":"Zhuang, Y. et al. Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor. Cell 185, 4361\u20134375.e19 (2022).","journal-title":"Cell"},{"key":"64882_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.50279","volume":"8","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q. et al. Common activation mechanism of class a GPCRs. Elife 8, 1\u201331 (2019).","journal-title":"Elife"},{"key":"64882_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cellsig.2017.01.016","volume":"32","author":"SS Schattauer","year":"2017","unstructured":"Schattauer, S. S., Kuhar, J. R., Song, A. & Chavkin, C. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor. Cell Signal 32, 59\u201365 (2017).","journal-title":"Cell Signal"},{"key":"64882_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/jpet.118.255661","volume":"371","author":"SW Kaski","year":"2019","unstructured":"Kaski, S. W. et al. Preclinical testing of nalfurafine as an opioid-sparing adjuvant that potentiates analgesia by the Mu opioid receptor-targeting agonist morphine. J. Pharmacol. Exp. Ther. 371, 487\u2013499 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"64882_CR32","doi-asserted-by":"publisher","unstructured":"Cao, D. et al. Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfura Fine and 42B, Its 3 - Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects. https:\/\/doi.org\/10.1021\/acschemneuro.0c00407 (2020).","DOI":"10.1021\/acschemneuro.0c00407"},{"key":"64882_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41386-018-0155-0","volume":"44","author":"JJ Liu","year":"2019","unstructured":"Liu, J. J. et al. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in \u03ba opioid aversion. Neuropsychopharmacology 44, 939\u2013949 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"64882_CR34","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1021\/acschemneuro.9b00195","volume":"10","author":"AD Dunn","year":"2019","unstructured":"Dunn, A. D., Reed, B., Erazo, J., Ben-Ezra, A. & Kreek, M. J. Signaling properties of structurally diverse kappa opioid receptor ligands: toward in vitro models of in vivo responses. ACS Chem. Neurosci. 10, 3590\u20133600 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"64882_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/mol.116.106419","volume":"91","author":"W Stallaert","year":"2017","unstructured":"Stallaert, W. et al. Purinergic receptor transactivation by the \u03b22-adrenergic receptor increases intracellular Ca2+ in nonexcitable cells. Mol. Pharm. 91, 533\u2013544 (2017).","journal-title":"Mol. Pharm."},{"key":"64882_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41594-021-00634-1","volume":"28","author":"HH Okamoto","year":"2021","unstructured":"Okamoto, H. H. et al. Cryo-EM structure of the human MT1\u2013Gi signaling complex. Nat. Struct. Mol. Biol. 28, 694\u2013701 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"64882_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111323","volume":"40","author":"R Suno","year":"2022","unstructured":"Suno, R. et al. Structural insights into the G protein selectivity revealed by the human EP3-Gi signaling complex. Cell Rep. 40, 111323 (2022).","journal-title":"Cell Rep."},{"key":"64882_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41592-019-0396-9","volume":"16","author":"M Schorb","year":"2019","unstructured":"Schorb, M., Haberbosch, I., Hagen, W. J. H., Schwab, Y. & Mastronarde, D. N. Software tools for automated transmission electron microscopy. Nat. Methods 16, 471\u2013477 (2019).","journal-title":"Nat. Methods"},{"key":"64882_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"64882_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"64882_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"64882_CR42","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","volume":"177","author":"A Inoue","year":"2019","unstructured":"Inoue, A. et al. Illuminating G-protein-coupling selectivity of GPCRs. Cell 177, 1933\u20131947.e25 (2019).","journal-title":"Cell"},{"key":"64882_CR43","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1038\/s41467-018-07094-0","volume":"9","author":"W Shihoya","year":"2018","unstructured":"Shihoya, W. et al. Crystal structures of human ET B receptor provide mechanistic insight into receptor activation and partial activation. Nat. Commun. 9, 4711 (2018).","journal-title":"Nat. Commun."},{"key":"64882_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112\u2013128 (2018).","journal-title":"Protein Sci."},{"key":"64882_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779\u2013815 (1993).","journal-title":"J. Mol. Biol."},{"key":"64882_CR46","unstructured":"Eswar, N. et al. Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinformatics. 0 5, Unit\u20135.6 (2014)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64882-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64882-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64882-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:04:34Z","timestamp":1761645874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64882-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64882"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64882-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9392"}}